Antibiotic heterogeneity: From concept to practice

Annals of the New York Academy of Sciences

Volumn 1213, Issue 1, 2010, Pages 81-91

  Bal, A M ^a,b   Kumar, A ^b   Gould, I M ^b  

^a CROSSHOUSE HOSPITAL   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Antibiotic cycling; Antibiotic diversity; Antibiotic mixing; Escherichia coli; Klebsiella; Mathematical models; MRSA; PAMS; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CLINICAL EDUCATION; DISEASE TRANSMISSION; HUMAN; INFECTION CONTROL; PRESCRIPTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; KLEBSIELLA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA;

EID: 78650372479     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05867.x     Document Type: Article

References (49)

1. Shlaes, D.M., D.N. Gerding, J.F. John Jr. et al. 1997. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect. Control Hosp. Epidemiol.18: 275-291.
2. Ibrahim, E.H., G. Sherman, S. Ward et al. 2000. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118: 146-155.
3. Kollef, M.H., G. Sherman, S. Ward & V.J. Fraser 1999. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115: 462-474.
4. Kumarasamy, K.K., M.A. Toleman, T.R. Walsh et al. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis.10: 597-602.
5. Bosso, J.A. 2004. The impact of antibiotic management on resistance. Pharmacotherapy 24(12 Pt 2): 224S-231S.
6. Levy, S.B. 1998. Multidrug resistance-a sign of the times. N. Engl. J. Med. 338: 1376-1378.
7. Trouillet, J.L., J. Chastre, A. Vuagnat et al. 1998. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am. J. Respir. Crit. Care Med. 157: 531-539.
8. Richards, M.J., J.R. Edwards, D.H. Culver & R.P. Gaynes 1999. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med. 27: 887-892.
9. McDonnell Norms Group. 2008. Antibiotic overuse: the influence of social norms. J. Am. Coll. Surg. 207: 265-275.
10. Sandiumenge, A., E. Diaz, A. Rodriguez et al. 2006. Impact of diversity of antibiotic use on development of antimicrobial resistance. J. Antimicrob. Chemother. 57: 1197-1204.
11. Bonhoeffer, S., M. Lipsitch & B.R. Levin 1997. Evaluating treatment protocols to prevent antibiotic resistance. Proc. Natl. Acad. Sci. USA.94: 12106-12111.
12. Lo, M., C.T. Bergstrom & M. Lipsitch 2002. Comparison of antimicrobial cycling and mixing using stochastic mathematical models. In Proceeding of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, Sept. 27-30, Abstract K-1345 2002.
13. Magee, J.T. 2005. The resistance ratchet: theoretical implications of cyclic selection pressure. J. Antimicrob. Chemother. 56: 427-430.
14. Bergstrom, C.T., M. Lo & M. Lipsitch 2004. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc. Natl. Acad. Sci. USA 101: 13285-13290.
15. Beardmore, R.E. & R. Pena-Miller 2010. Antibiotic cycling versus mixing: the difficulty of using mathematical models to definitively quantify their relative merits. Math. Biosci. Eng. 7: 923-933.
16. Reluga, T.C. 2005. Simple models of antibiotic cycling. Math. Med. Biol. 22: 187-208.
17. Sun, H.R., X. Lu & S. Ruan 2010. Qualitative analysis of models with different treatment protocols to prevent antibiotic resistance. Math. Biosci. 2 27 56-67.
18. Gerding, D.N., T.A. Larson, R.A. Hughes et al. 1991. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob. Agents Chemother. 35: 1284-1290.
19. Gruson, D., G. Hilbert, F. Vargas et al. 2000. Rotation and restricted use of antibiotics in a medical intensive care unit. Am. J. Respir. Crit. Care Med. 162: 837-843.
20. Bradley, S.J., A.L. Wilson, M.C. Allen et al. 1999. The control of hyperendemic glycopeptides-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage. J. Antimicrob. Chemother. 43: 261-266.
21. Van Loon, H., M. Vriens, A. Fluit et al. 2005. Antibiotic rotation and development of Gram-negative antibiotic resistance. Am. J. Respir. Crit. Care Med. 171: 480-487.
22. Moss, W.J., M.C. Beers, E. Johnson et al. 2002. Pilot study of antibiotic cycling in paediatric intensive care unit. Crit. Care Med. 30: 1877-1882.
23. Warren, D.K., H.A. Hill, L.R. Merz et al. 2004. Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients. Crit. Care Med. 32: 2450-2456.
24. Bruno-Murtha, L.A., J. Brusch, D. Bor et al. 2005. A pilot study of antibiotic cycling in the community hospital setting. Infect. Control Hosp. Epidemiol. 26: 81-87.
25. Merz, L.R., D.K. Warren, M.H. Kollef et al. 2006. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Chest 130: 1672-1678.
26. Merz, L.R., D.K. Warren, M.H. Kollef & V.J. Fraser 2004. Effects on antibiotic cycling program on antibiotic prescribing practices in an intensive care unit. Antimicrob. Agents Chemother. 48: 2861-2865.
27. Gruson, D., G. Hilbert, F. Vargas et al. 2003. Strategy of antibiotic rotation. Long term effect on incidence and susceptibilities of gram negative bacilli responsible for ventilator-associated pneumonia. Crit. Care Med. 31: 1908-1914.
28. Toltzis, P., M.J. Dul, C. Hoyen et al. 2002. The effect of antibiotic rotation on colonization with antibiotic -resistant bacilli in neonatal intensive care unit. Paediatrics 110: 707-711.
29. Martínez, J.A., J.M. Nicolás, F. Marco et al. 2005. Comparison of antimicrobial cycling and mixing in two medical intensive care units. Crit. Care Med. 34: 329-336.
30. Tsukayama, D.T., H.J. van Loon, C. Cartwright et al.; RADAR Trial. 2004. The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial. Int. J. Antimicrob. Agents. 24: 339-345.
31. Masterton, R. 2005. Antibiotic cycling: more than it might seem? J. Antimicrob. Chemother. 55: 1-5.
32. Brown, E.M. & D. Nathwani 2005. Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. J. Antimicrob. Chemother. 55: 6-9.
33. Soler Bistué, A.J., F.A. Martín, N. Vozza et al. 2009. Inhibition of aac(6')-Ib-mediated amikacin resistance by nuclease-resistant external guide sequences in bacteria. Proc. Natl. Acad. Sci. USA 106: 13230-13235.
34. Bennett, K.M., J.E. Scarborough, M. Sharpe et al. 2007. Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit. J. Trauma 63: 307-311.
35. Raineri, E., L. Crema, S. Dal Zoppo et al. 2010. Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 29: 1015-1024.
36. Raymond, D.P., S.J. Pelletier, T.D. Crabtree et al. 2001. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit. Care Med. 29:1101-1108.
37. Craig, M., A.D. Cumpston, G.R. Hobbs et al. 2007. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit. Bone Marrow Transplant. 39: 477-482.
38. Pakyz, A.L. & B.M. Farr 2009. Rates of Stenotrophomonas maltophilia colonization and infection in relation to antibiotic cycling protocols. Epidemiol. Infect. 137: 1679-1683.
39. Nijssen, S., A. Fluit, D. van de Vijver et al. 2010. Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteria. Intensive Care Med. 36: 512-519.
40. Smith, R.L., H.L. Evans, T.W. Chong et al. 2008. Reduction in rates of methicillin-resistant Staphylococcus aureus infection after introduction of quarterly linezolid-vancomycin cycling in a surgical intensive care unit. Surg. Infect. (Larchmt.) 9: 423-431.
41. Takesue, Y., K. Nakajima, K. Ichiki et al. 2010. Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria. J. Hosp. Infect. 75: 28-32.
42. Takesue, Y., H. Ohge, M. Sakashita et al. 2006. Effect of antibiotic heterogeneity on the development of infections with antibiotic-resistant gram-negative organisms in a non-intensive care unit surgical ward. World J. Surg. 30: 1269-1276.
43. Young, E.J., C.M. Sewell, M.A. Koza & J.E. Clarridge 1985. Antibiotic resistance patterns during aminoglycoside restriction. Am. J. Med. Sci. 290: 223-227.
44. Hedrick, T.L., A.S. Schulman, S.T. McElearney et al. 2008. Outbreak of resistant Pseudomonas aeruginosa infections during a quarterly cycling antibiotic regimen. Surg. Infect. (Larchmt.) 9: 139-152.
45. Kumar, R., K. Indira, A. Rizvi et al. 2008. Antibiotic prescribing practices in primary and secondary health care facilities in Uttar Pradesh, India. J. Clin. Pharm. Ther. 33: 625-634.
46. McNulty, C.A. & N.A. Francis 2010. Optimizing antibiotic prescribing in primary care settings in the UK: findings of a BSAC multi-disciplinary workshop 2009. J. Antimicrob. Chemother. 65: 2278-2284.
47. Chastre, J., M. Wolff, J.Y. Fagon, et al.; PneumA Trial Group. 2003. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290: 2588-2598.
48. Pugh, R.J., R.P. Cooke & G. Dempsey 2010. Short course antibiotic therapy for Gram-negative hospital-acquired pneumonia in the critically ill. J. Hosp. Infect. 74: 337-343.
49. Bouadma, L., C.E. Luyt, F. Tubach, et al.; PRORATA Trial Group. 2010. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375: 463-474.